Southeastern Clinical Research Institute, LLC (SCRI) is an Independent Clinical Research Institute incorporated in 2005.
Located in Augusta, Georgia, we specialize in conducting clinical trials for patients dealing with various types of kidney disease. We are always discussing and reviewing new clinical trials to bring to our patient population. Having participated in over 100 clinical trials, we actively participate in bringing novel, life-changing medications to market.
Southeastern Clinical Research Institute has conducted phase IB-IV clinical trials since 2005 in the following therapeutic areas
CKD
Cardiovascular Disease and CKD
Anemia
Diabetes Mellitus
Dialysis Access
Hyperparathyroidism
Hyperphosphatemia
Hypertension
Iron Deficiency
Glomerulonephritis
Proteinuria
Hyperlipidemia
Kidney Disease
Immunology
Polycystic kidney disease
Lupus Nephritis
Actively Enrolling Clinical Trials
Regulus Therapeutics: RGLS8429-02
/in Clinical TrialsThe primary objective of this study is to evaluate the safety and tolerability of the study drug RGLS829 in adults with autosomal dominant polycystic kidney disease (ADPKD). The study also aims to assess the impact of RGLS8429 on ADPKD biomarkers, height-adjusted total kidney volume (htTKV), and renal function in those living with ADPKD.
Mineralys Therapeutics Inc.: MLS-101-202
/in Clinical TrialsA Phase 2 trial to evaluate the blood pressure-lowering effect of lorundrostat (an aldosterone synthase inhibitor), administered on a background of a standardized anti-hypertensive (AHT) medication regimen, in subjects with uncontrolled and/or treatment-resistant hypertension.